ALKERMES reported $50.62M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US USD 4.23B 86M
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Acorda Therapeutics ACOR:US USD 11M 2.2M
Amgen AMGN:US USD 1.75B 159M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Coherus Biosciences CHRS:US USD 35.23M 23.96M
Eli Lilly And LLY:US USD 1.55B 31M
Gilead Sciences GILD:US USD 1.4B 1000K
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Horizon Pharma HZNP:US USD 234.13M 3.92M
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M
IONIS PHARMACEUT IONS:US USD 1.52M 3.23M
JAZZ PHA JAZZ:US USD 133.66M 9.45M
Johnson & Johnson JNJ:US USD 7.76B 29M
Merk MRK:US USD 3.36B 519M
Nektar Therapeutics NKTR:US USD 4.97M 143K
Neurocrine Biosciences NBIX:US USD 6.1M 1.3M
Otsuka Holdings 4578:JP JPY 152.73B 4.78B
Pfizer PFE:US USD 9.82B 3.73B
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Revance Therapeutics RVNC:US USD 10.74M 1.21M
Teva Pharmaceutical Industries TEVA:US USD 1.88B 73M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M